The identification of SF3B1 as a CYCLOPS gene highlights a previously unrecognized cancer vulnerability and implicates non-driver alterations of wild-type SF3B1 as a potential therapeutic target present in 11% of all cancers. The gene discussed is SF3B1; the disease is cancer.